Is CHEPLAPHARM ARZNEIMITTEL GMBH FDA approved?

CHEPLAPHARM ARZNEIMITTEL GMBH holds no registered establishment of its own; it appears here on its Orange Book patents.

Are any CHEPLAPHARM ARZNEIMITTEL GMBH products in shortage?

3 presentations are currently listed in the FDA drug shortage database under CHEPLAPHARM ARZNEIMITTEL GMBH, covering Clonazepam Tablet.

CHEPLAPHARM ARZNEIMITTEL GMBH

Data as of 2 Oct 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 0
Live patents: 2
Shortage listings: 3
Countries: 0

Alert

Drug shortage listings

Drug	Presentation	Status	Availability	Posted / updated
Clonazepam TabletNeurology, Pediatric, Psychiatry	Klonopin, Tablet, .5 mg (NDC 61269-605-10)	Current	Available	10 Mar 20232 Oct 2026
Clonazepam TabletNeurology, Pediatric, Psychiatry	Klonopin, Tablet, 1 mg (NDC 61269-610-10)	Current	Available	10 Mar 20232 Oct 2026
Clonazepam TabletNeurology, Pediatric, Psychiatry	Klonopin, Tablet, 2 mg (NDC 61269-620-10)	Current	Available	10 Mar 202316 Sept 2026

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
8889109	VALCYTEvalganciclovir hydrochloride	product	Dec 2027
9642911	VALCYTEvalganciclovir hydrochloride	product	Dec 2027

Enquiry

Common questions

Is CHEPLAPHARM ARZNEIMITTEL GMBH FDA approved?: CHEPLAPHARM ARZNEIMITTEL GMBH holds no registered establishment of its own; it appears here on its Orange Book patents.
Are any CHEPLAPHARM ARZNEIMITTEL GMBH products in shortage?: 3 presentations are currently listed in the FDA drug shortage database under CHEPLAPHARM ARZNEIMITTEL GMBH, covering Clonazepam Tablet.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.